Clinical Trial Update: Comparison Among Erythropoietin Stimulating Agents [Phase 4]

View source ↗

Summary

Phase 4 trial comparing erythropoietin stimulating agents in anemia of end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of End Stage Renal Disease

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Anemia of End Stage Renal Disease | Phase 4 | Status: COMPLETED